PDE4D and metabolic syndrome: Obesity and metabolic syndrome are considered risk factors for AF, with meta-analyses showing increased AF incidence with elevated total cholesterol levels.[50] The correlation between cyclic adenosine phosphate and AF, as discussed earlier, suggests PDE4D as a potential target for activating the cAMP signaling pathway.